{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:02Z","timestamp":1707524702415},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,2]]},"DOI":"10.7759\/cureus.32135","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T18:32:00Z","timestamp":1670005920000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Aggressive Systemic Mastocytosis With Skeletal Osteosclerotic Lesions on Presentation: A Diagnostic Conundrum"],"prefix":"10.7759","author":[{"given":"Rina","family":"Ghorpade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Tissavirasingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh","family":"Vennepureddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2021.068","article-title":"Systemic mastocytosis: multidisciplinary approach","volume":"13","author":"Zanotti R","year":"2021","unstructured":"Zanotti R, Tanasi I, Crosera L, et al.. Systemic mastocytosis: multidisciplinary approach. Mediterr J Hematol Infect Dis. 2021, 13:e2021068. 10.4084\/MJHID.2021.068","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21218","article-title":"Gastrointestinal involvement and manifestations in systemic mastocytosis","volume":"16","author":"Sokol H","year":"2010","unstructured":"Sokol H, Georgin-Lavialle S, Grandpeix-Guyodo C, et al.. Gastrointestinal involvement and manifestations in systemic mastocytosis. Inflamm Bowel Dis. 2010, 16:1247-53. 10.1002\/ibd.21218","journal-title":"Inflamm Bowel Dis"},{"key":"ref4","article-title":"Mastocytosis presenting as a skeletal disorder","volume":"16","author":"Delsignore JL","year":"1996","unstructured":"Delsignore JL, Dvoretsky PM, Hicks DG, O'Keefe RJ, Rosier RN. Mastocytosis presenting as a skeletal disorder. Iowa Orthop J. 1996, 16:126-34.","journal-title":"Iowa Orthop J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00620","article-title":"Mast cell: a multi-functional master cell","volume":"6","author":"Krystel-Whittemore M","year":"2015","unstructured":"Krystel-Whittemore M, Dileepan KN, Wood JG. Mast cell: a multi-functional master cell. Front Immunol. 2015, 6:620. 10.3389\/fimmu.2015.00620","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1590\/1516-3180.2013.1313460","article-title":"Indolent systemic mastocytosis limited to the bone: a case report and review of the literature","volume":"131","author":"Pinto-Lopes P","year":"2013","unstructured":"Pinto-Lopes P, Fonseca FA, Silva R, Hafe Pv, Fonseca E. Indolent systemic mastocytosis limited to the bone: a case report and review of the literature. Sao Paulo Med J. 2013, 131:198-204. 10.1590\/1516-3180.2013.1313460","journal-title":"Sao Paulo Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1232","article-title":"Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis","volume":"5","author":"Bonifacio M","year":"2017","unstructured":"Bonifacio M, Zanotti R, Guardalben E, et al.. Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis. Clin Case Rep. 2017, 5:1988-91. 10.1002\/ccr3.1232","journal-title":"Clin Case Rep"},{"key":"ref8","article-title":"Systemic mastocytosis: current concepts and treatment advances","volume":"3","author":"Tefferi A","year":"2004","unstructured":"Tefferi A, Pardanani A. Systemic mastocytosis: current concepts and treatment advances. Curr Hematol Rep. 2004, 3:197-202.","journal-title":"Curr Hematol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.03.044","article-title":"Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis","volume":"146","author":"Hartmann K","year":"2020","unstructured":"Hartmann K, Gotlib J, Akin C, et al.. Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis. J Allergy Clin Immunol. 2020, 146:356-66.e4. 10.1016\/j.jaci.2020.03.044","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","unstructured":"U.S. Food and Drug Administration - Center for Drug Evaluation and Research. FDA approves avapritinib for advanced systemic mastocytosis. (2022). Accessed: September 5, 2022: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-avapritinib-advanced-systemic-mastocytosis."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/123915-a-rare-case-of-aggressive-systemic-mastocytosis-with-skeletal-osteosclerotic-lesions-on-presentation-a-diagnostic-conundrum","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:54Z","timestamp":1707508314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/123915-a-rare-case-of-aggressive-systemic-mastocytosis-with-skeletal-osteosclerotic-lesions-on-presentation-a-diagnostic-conundrum"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.32135","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,2]]}}}